Correlation Between InfuSystems Holdings and Singular Genomics
Can any of the company-specific risk be diversified away by investing in both InfuSystems Holdings and Singular Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining InfuSystems Holdings and Singular Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between InfuSystems Holdings and Singular Genomics Systems, you can compare the effects of market volatilities on InfuSystems Holdings and Singular Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in InfuSystems Holdings with a short position of Singular Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of InfuSystems Holdings and Singular Genomics.
Diversification Opportunities for InfuSystems Holdings and Singular Genomics
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between InfuSystems and Singular is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding InfuSystems Holdings and Singular Genomics Systems in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Singular Genomics Systems and InfuSystems Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on InfuSystems Holdings are associated (or correlated) with Singular Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Singular Genomics Systems has no effect on the direction of InfuSystems Holdings i.e., InfuSystems Holdings and Singular Genomics go up and down completely randomly.
Pair Corralation between InfuSystems Holdings and Singular Genomics
Given the investment horizon of 90 days InfuSystems Holdings is expected to generate 1.61 times less return on investment than Singular Genomics. But when comparing it to its historical volatility, InfuSystems Holdings is 2.92 times less risky than Singular Genomics. It trades about 0.37 of its potential returns per unit of risk. Singular Genomics Systems is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest 1,332 in Singular Genomics Systems on August 28, 2024 and sell it today you would earn a total of 805.00 from holding Singular Genomics Systems or generate 60.44% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
InfuSystems Holdings vs. Singular Genomics Systems
Performance |
| Timeline |
| InfuSystems Holdings |
| Singular Genomics Systems |
InfuSystems Holdings and Singular Genomics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with InfuSystems Holdings and Singular Genomics
The main advantage of trading using opposite InfuSystems Holdings and Singular Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if InfuSystems Holdings position performs unexpectedly, Singular Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Singular Genomics will offset losses from the drop in Singular Genomics' long position.| InfuSystems Holdings vs. Electromed | InfuSystems Holdings vs. Issuer Direct Corp | InfuSystems Holdings vs. IRIDEX | InfuSystems Holdings vs. Milestone Scientific |
| Singular Genomics vs. EUDA Health Holdings | Singular Genomics vs. Nutex Health | Singular Genomics vs. Healthcare Triangle | Singular Genomics vs. Mangoceuticals, Common Stock |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |